Kathleen L Behr — Fresno, California

Kathleen L Behr is a clinical research site located in Fresno, California, United States 93720.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Kathleen L Behr has participated in 1 clinical trials.

Therapeutic areas: Submental Fullness.

Sponsors: Kythera Biopharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fresno

Browse all research sites in California · View every site in Fresno

• VA Central California Health C /ID# 170951
• Saint Helena Hospital
• University of California San Francisco
• Fresno State University
• University California San Francisco
• VA Central California Health Care System, Fresno, CA
• VA Medical Center, Fresno
• University Oncology Associates
• University California San Francisco - Fresno
• VA Central California Health Care System /ID# 200047
• University of California, San Francisco (UCSF) Fresno
• VA Central California Healthcare

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kathleen L Behr?

Kathleen L Behr has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kathleen L Behr conducted?

Kathleen L Behr has 1 clinical trials on record. Their work covers Submental Fullness.

Is Kathleen L Behr accredited by Crixeo Clinical Trials?

Kathleen L Behr has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Kathleen L Behr?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.